Skip to main content

Table 1 Prevalence and determinants of transmitted drug resistance (TDR) among the participants

From: Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020–2023

Variables

N (%)a

TDR (%)

X2

P-value

OR (95%CI)

P-value

Adjusted OR(95%CI)b

P-value

Sex

        

Female

321(18.0%)

22(6.9%)

0.334

0.563

1

   

Male

1461(82.0%)

79(5.4%)

  

0.777(0.485–1.295)

0.311

  

age

        

< 30

366(20.5%)

17(4.6%)

0.045

0.978

1

   

30–49

660(37.0%)

35(5.3%)

  

1.150(0.644–2.130)

0.645

  

≥ 50

756(42.5%)

49(6.5%)

  

1.423(0.824–2.576)

0.222

  

Marital status

        

Single

605(33.9%)

29(4.8%)

1.937

0.586

1

   

Married

737(41.4%)

40(5.4%)

  

1.140(0.700-1.877)

0.601

  

Divorced/widowed

414(23.2%)

28(6.8%)

  

1.445(0.843–2.471)

0.178

  

Uknown

26(1.5%)

4(15.4%)

  

3.454(0.967–9.721)

0.031

  

Education

        

Primary

657(36.9%)

46(7%)

1.819

0.769

1

   

Junior

630(35.3%)

37(4.3%)

  

0.829(0.527–1.294)

0.411

  

Senior

249(14%)

9(3.6%)

  

0.498(0.225–0.986)

0.061

  

College

242(13.6%)

9(3.7%)

  

0.513(0.232–1.016)

0.073

  

Unknown

4(0.2%)

0

  

0

0

  

Ethnicity

        

Ethnic minorities

95(5.3%)

5(5.2%)

0.049

0.976

1

   

Han

1686(94.6%)

96(5.7%)

  

1.087(0.476–3.138)

0.860

  

Unknown

1(0.1%)

0

  

0

0

  

Transmission route

Heterosexual

1114(62.5%)

64(5.7%)

5.279

0.153

1

   

Homosexual

618(34.7%)

31(5.0%)

  

0.866(0.551–1.335)

0.524

  

Other

5(0.3%)

1(2.0%)

  

4.102(0.208–28.225)

0.210

  

Unknown

45(2.5%)

5(11.1%)

  

2.051(0.690–4.931)

0.144

  

CD4 + T cell count(cells/mm3)

< 200

655(37.4%)

19(2.9%)

7.772

0.021

1

   

200–499

907(51.9%)

28(3.1%)

  

0.860(0.543–1.369)

0.521

0.845(0.521–1.376)

0.495

≥ 500

188(10.7%)

13(6.9%)

  

2.003(1.098–3.554)

0.020

2.188(1.158–4.033)

0.013

Subtypes

        

CRF01_AE

504(28.3%)

40(7.9%)

  

1

   

CRF07_BC

928(52.1%)

25(2.7%)

  

0.320(0.190–0.531)

1.30E-05

1.401(0.284–25.369)

7.14E-06

CRF08_BC

131(7.3%)

31(23.7%)

  

3.588(2.131–6.006)

1.24E-06

18.585(3.792-336.183)

1.29E-06

other

219(12.3%)

5(2.3%)

  

0.270(0.092–0.634)

0.007

0

0.006

Year

        

2020

521(29.2%)

31(5.9%)

6.680

0.083

1

   

2021

512(28.7%)

21(4.1%)

  

0.676(0.378–1.186)

0.177

0.770(0.450–2.138)

0.386

2022

426(24.0%)

20(4.7%)

  

0.779(0.431–1.377)

0.396

0.947(0.701–3.207)

0.864

2023

323 (18.1%)

29(9.0%)

  

1.559(0.917–2.643)

0.098

1.834(1.114–4.893)

0.039

  1. a N: Number of Individuals b Adjusted for CD4 + T cell count, Year, Subtype